EUS- and US- Guided Biopsy for Pancreatic Lesion
ConditionPancreatic Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorTian'an Jiang
About this trial
Endoscopic ultrasound (EUS) and ultrasound (US) are the two primary imaging modalities used to guide pancreatic needle biopsy. This study aimed to compare the diagnostic performance and complications associated with EUS- and US-guided pancreatic biopsies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Between January 2017 and December 2023, 2663 consecutive patients with focal pancreatic disease underwent 2729 procedures for pancreatic tissue acquisition from focal pancreatic lesions at seven university teaching hospitals in China.
Disqualifiers
Patients were excluded from the study if they had less than 12 months of follow-up, were lost to follow-up, had incomplete follow-up data, or underwent intraoperative biopsy or fluid aspiration.
Trial population
consecutive patients with focal pancreatic disease underwent procedures for pancreatic tissue acquisition
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
sampling tissue
Other interventionEUS- and US- guided pancreatic biopsy
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
diagnostic inaccuracy
Time frame
1-yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Tian'an Jiang
Lead sponsor
First Affiliated Hospital of Zhejiang University
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: